MyositisPIMANTNCT07552220
Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence Tomography
An observational study of Myositis and Health Adult Subjects, run by Centre Hospitalier de Mâcon at 1 site in France.
Trial summary
Myositis is an inflammatory disease of the skeletal muscles that can be caused by infections, autoimmune diseases, or medications. Early diagnosis of these conditions is essential for optimal treatment. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Myositis, Health Adult Subjects
- How many people
- 20 participants
- Where
- 1 siteFrance
- Study dates
- Apr 2026to Dec 2028
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Myositis or healthy major patients
Who may be able to join
- Patient > 18 years old ans has given his oral consent
- Patient who biospies are performed as part of care
Who cannot join
- Patient < 18 years old
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Myositis is an inflammatory disease of the skeletal muscles that can be caused by infections, autoimmune diseases, or medications. Early diagnosis of these conditions is essential for optimal treatment. Anatomic pathology is the conventional method used to analyze muscle lesions, but it requires several weeks to obtain results. Full-field optical coherence tomography (OCT), a non-invasive imaging technique, could offer advantages in terms of speed and resolution for visualizing muscle inflammation.
This research project compares histological pathology and full-field OCT for the analysis of muscle biopsies from healthy individuals and patients suspected of having myositis. The aim of this study is to establish an OCT reference standard by analyzing control muscle biopsies and then comparing muscle inflammation in confirmed cases of myositis. The advantages and limitations of both methods will also be evaluated.
Read the detailed description
Introduction Myositis represents a group of inflammatory diseases affecting skeletal muscles, characterized by inflammatory infiltration of muscle tissue. This condition can have various etiologies, such as infections, autoimmune diseases (like dermatomyositis or polymyositis), or drug-induced diseases. Early diagnosis and accurate assessment of muscle inflammation are essential for the therapeutic management of these patients.
Conventional analytical techniques, such as histopathology, allow visualization and analysis of muscle lesions and inflammation using stains on histological sections. However, this method requires several weeks of work before a result can be obtained. Full-field optical coherence tomography (OCT), a non-invasive imaging technique, could offer significant advantages in terms of speed of examination and resolution of muscle structures, particularly for visualizing inflammatory infiltration.
This research project proposes to compare conventional histopathology and full-field optical coherence tomography for the analysis of muscle biopsies from both healthy individuals and patients with suspected myositis.
The main objective of this prospective and comparative study will be to first establish a reference standard by analyzing control biopsies using both methods, and then to similarly evaluate the muscle inflammation detected in confirmed cases of myositis. The respective advantages and limitations of each technique will be assessed in the detection of this pathology.
Research Objectives
- To analyze the spatial resolution of both methods for visualizing histopathological details at the level of muscle fibers, connective tissue, and blood vessels.
- To compare the ability of conventional histopathology and full-field optical coherence tomography (OCT) to detect muscle inflammation in muscle biopsies from healthy individuals and patients with myositis.
- To evaluate the diagnostic accuracy of both techniques in identifying inflammation-related abnormalities, such as inflammatory cell infiltration (lymphocytes, macrophages), muscle fiber degradation, and fibrosis.
- To compare the acquisition time and ease of use of each method for analyzing muscle tissue in a clinical setting.
Hypotheses Full-field optical coherence tomography will enable real-time visualization of inflammatory infiltration and muscle abnormalities with microscopic resolution, in a non-invasive, rapid, and dynamic manner.
These results could very quickly complement those obtained by anatomopathology which aims to describe the classic histopathological aspects of myositis, such as muscle necrosis, inflammatory infiltration, and fibrosis.
Methodology
- Sample Selection
- Patient Groups:
- Group 1 (healthy patients): Muscle biopsies from approximately ten healthy adult patients with no history of muscular, neurodegenerative, or inflammatory disease, undergoing orthopedic surgery. The age range should be variable (18-90 years) to be representative of the population and to account for natural age-related atrophy.
- Group 2 (patients with suspected myositis): Muscle biopsies from adult patients presenting with clinical symptoms consistent with myositis (muscle fatigue, pain, muscle weakness) and clinical suspicion confirmed by other diagnostic tests (e.g., serology, EMG, clinical examination). Healthy muscle tissue will be obtained from a resection necessary during orthopedic surgery. This surgical waste does not constitute additional samples. Biopsies for suspected myositis will be performed as part of the diagnostic process and do not require any additional sampling. An information sheet will be given to the patient, and the surgeon will obtain their consent before the procedure. All patients must be of legal age, affiliated with or covered by the social security system, and not subject to any legal guardianship or protective measures. Pregnant women and adults unable to express their consent cannot be included in the research protocol.
- Conventional Anatomopathological Analysis
- Samples will be frozen in ispoentane, stored at -80°C, and then transported on dry ice to the Anatomopathology Department of the Hospices Civils de Lyon for section labeling.
- Histological staining of healthy tissues: Three standard stains will be performed on control biopsies (hematoxylin and eosin (H\&E), Gomori stain, fiber typing) to collect structural and metabolic data.
- Histological staining in cases of suspected myositis: The three standard stains will also be performed, as well as stains for inflammatory markers, namely the major histocompatibility complex (HLA I, HLA DR), complement (C5b9), autophagy (p62), and clusters of differentiation (CD56, CD31).
- Full-field optical coherence tomography (OCT) analysis
- Full-field OCT technology allows for micrometer-resolution imaging without the need for prior sample preparation. OCT will be used to image muscle tissue samples in real time, both structurally (FF-OCT) and dynamically (DCI). A series of 1 µm slices will be acquired. The images will then be converted by an algorithm to reproduce hematoxylin and eosin staining.
- OCT images could allow visualization of muscle fiber structure, surrounding connective tissue, and areas of inflammatory infiltration.
- Comparison of methods Qualitative analysis: The images obtained by OCT will be visually compared to images obtained by conventional histology after scanning the slides. This comparison will be conducted by specialized anatomical pathologists to evaluate the ability of each method to detect muscle abnormalities and inflammation. An artificial intelligence algorithm may be used to facilitate the comparison.
- Expected Results The results will allow us to evaluate the clinical value of OCT as an alternative or complementary imaging method to conventional histopathology. If OCT proves effective for detecting muscle inflammation, it could become a valuable tool for ultra-rapid diagnosis.
- Conditions
- Myositis, Health Adult Subjects
- Keywords
- anatomopathology, Full field optical coherence tomography, muscle biopsies, Myositis and healthy patients
- Medical subject headings
- Myositis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Healthy patients | Muscle biopsies collected during orthopedic surgery (performed as part of care) | |
| Myositis patients | Muscle biopsies collected as part of care to establish a diagnosis |
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluation of the spatial resolution of the two methods
Image acquisitions will be performed on the same samples (fresh tissue for OCT and frozen tissue for histology) with an identical section thickness.
To obtain structural tissue data, OCT acquisitions will be performed in full field mode (FF-OCT), and Hematoxylin-Eosin, Gomori's trichrome and NADH staining will be carried out on histological sections.
For each method, the criteria evaluated will be the ability to detect fiber structure, the presence of fibrosis and blood vessels.
Image comparison will be performed by specialized pathologists and then by an autoML type artificial intelligence, with assessment of accuracy and recall.
Measured: 2 years
Evaluation of inflammation detection of the two methods
Image acquisition will be performed on the same samples (fresh tissue for OCT and frozen tissue for histology) with an identical section thickness.
OCT acquisitions will be carried out in dynamic colorimetric mode (DCI) to observe the intensity and variability of metabolic activity across the entire fresh tissue sample using a color panel ranging from blue to red.
Inflammation detection on histological sections will be observed using the markers HLA1, HLA-DR, C5B9, P62, CD31, CD56. The potential correlation between metabolic activity and inflammation will be visually assessed by specialized pathologists and by an autoML type artificial intelligence with assessment of accuracy and recall.
Measured: 2 years
Secondary outcomes (1)
Establish the advantages and limitations of the two methods
Define the averages for sample preparation time, acquisition time and result delivery time for each method.
Compare the quality of the results obtained by the two techniques according to the two previous evaluation criteria (visual assessment by pathologists, accuracy, recall and AI F1 score)
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Apr 2026
- Study startApr 2026 (estimated)
- Primary completionApr 2028 (estimated)
- Study completionDec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MyositisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 20 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier de Mâcon
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Thibault MAILLET, Centre Hospitalier de Mâcon
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07552220
- Sponsor's protocol ID
- PIMANT
- Acronym
- PIMANT
- Status last verified
- Apr 2026
- First submitted
- 3 Apr 2026
- Last updated
- 27 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence Tomography
- ClinicalTrials.gov ID
- NCT07552220
- Acronym / sponsor ID
- PIMANT / PIMANT
- Conditions
- Myositis, Health Adult Subjects
- Keywords
- anatomopathology, Full field optical coherence tomography, muscle biopsies, Myositis and healthy patients
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- Centre Hospitalier de MâconUniversity, hospital or other
- Study start
- Apr 2026 (estimated)
- Primary completion
- Apr 2028 (estimated)
- Study completion
- Dec 2028 (estimated)
- First posted
- 27 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Myositis is an inflammatory disease of the skeletal muscles that can be caused by infections, autoimmune diseases, or medications. Early diagnosis of these conditions is essential for optimal treatment. Anatomic pathology is the conventional method used to analyze muscle lesions, but it requires several weeks to obtain results. Full-field optical coherence tomography (OCT), a non-invasive imaging technique, could offer advantages in terms of speed and resolution for visualizing muscle inflammation.
This research project compares histological pathology and full-field OCT for the analysis of muscle biopsies from healthy individuals and patients suspected of having myositis. The aim of this study is to establish an OCT reference standard by analyzing control muscle biopsies and then comparing muscle inflammation in confirmed cases of myositis. The advantages and limitations of both methods will also be evaluated.
Detailed description
Introduction Myositis represents a group of inflammatory diseases affecting skeletal muscles, characterized by inflammatory infiltration of muscle tissue. This condition can have various etiologies, such as infections, autoimmune diseases (like dermatomyositis or polymyositis), or drug-induced diseases. Early diagnosis and accurate assessment of muscle inflammation are essential for the therapeutic management of these patients.
Conventional analytical techniques, such as histopathology, allow visualization and analysis of muscle lesions and inflammation using stains on histological sections. However, this method requires several weeks of work before a result can be obtained. Full-field optical coherence tomography (OCT), a non-invasive imaging technique, could offer significant advantages in terms of speed of examination and resolution of muscle structures, particularly for visualizing inflammatory infiltration.
This research project proposes to compare conventional histopathology and full-field optical coherence tomography for the analysis of muscle biopsies from both healthy individuals and patients with suspected myositis.
The main objective of this prospective and comparative study will be to first establish a reference standard by analyzing control biopsies using both methods, and then to similarly evaluate the muscle inflammation detected in confirmed cases of myositis. The respective advantages and limitations of each technique will be assessed in the detection of this pathology.
Research Objectives
- To analyze the spatial resolution of both methods for visualizing histopathological details at the level of muscle fibers, connective tissue, and blood vessels.
- To compare the ability of conventional histopathology and full-field optical coherence tomography (OCT) to detect muscle inflammation in muscle biopsies from healthy individuals and patients with myositis.
- To evaluate the diagnostic accuracy of both techniques in identifying inflammation-related abnormalities, such as inflammatory cell infiltration (lymphocytes, macrophages), muscle fiber degradation, and fibrosis.
- To compare the acquisition time and ease of use of each method for analyzing muscle tissue in a clinical setting.
Hypotheses Full-field optical coherence tomography will enable real-time visualization of inflammatory infiltration and muscle abnormalities with microscopic resolution, in a non-invasive, rapid, and dynamic manner.
These results could very quickly complement those obtained by anatomopathology which aims to describe the classic histopathological aspects of myositis, such as muscle necrosis, inflammatory infiltration, and fibrosis.
Methodology
- Sample Selection
- Patient Groups:
- Group 1 (healthy patients): Muscle biopsies from approximately ten healthy adult patients with no history of muscular, neurodegenerative, or inflammatory disease, undergoing orthopedic surgery. The age range should be variable (18-90 years) to be representative of the population and to account for natural age-related atrophy.
- Group 2 (patients with suspected myositis): Muscle biopsies from adult patients presenting with clinical symptoms consistent with myositis (muscle fatigue, pain, muscle weakness) and clinical suspicion confirmed by other diagnostic tests (e.g., serology, EMG, clinical examination). Healthy muscle tissue will be obtained from a resection necessary during orthopedic surgery. This surgical waste does not constitute additional samples. Biopsies for suspected myositis will be performed as part of the diagnostic process and do not require any additional sampling. An information sheet will be given to the patient, and the surgeon will obtain their consent before the procedure. All patients must be of legal age, affiliated with or covered by the social security system, and not subject to any legal guardianship or protective measures. Pregnant women and adults unable to express their consent cannot be included in the research protocol.
- Conventional Anatomopathological Analysis
- Samples will be frozen in ispoentane, stored at -80°C, and then transported on dry ice to the Anatomopathology Department of the Hospices Civils de Lyon for section labeling.
- Histological staining of healthy tissues: Three standard stains will be performed on control biopsies (hematoxylin and eosin (H\&E), Gomori stain, fiber typing) to collect structural and metabolic data.
- Histological staining in cases of suspected myositis: The three standard stains will also be performed, as well as stains for inflammatory markers, namely the major histocompatibility complex (HLA I, HLA DR), complement (C5b9), autophagy (p62), and clusters of differentiation (CD56, CD31).
- Full-field optical coherence tomography (OCT) analysis
- Full-field OCT technology allows for micrometer-resolution imaging without the need for prior sample preparation. OCT will be used to image muscle tissue samples in real time, both structurally (FF-OCT) and dynamically (DCI). A series of 1 µm slices will be acquired. The images will then be converted by an algorithm to reproduce hematoxylin and eosin staining.
- OCT images could allow visualization of muscle fiber structure, surrounding connective tissue, and areas of inflammatory infiltration.
- Comparison of methods Qualitative analysis: The images obtained by OCT will be visually compared to images obtained by conventional histology after scanning the slides. This comparison will be conducted by specialized anatomical pathologists to evaluate the ability of each method to detect muscle abnormalities and inflammation. An artificial intelligence algorithm may be used to facilitate the comparison.
- Expected Results The results will allow us to evaluate the clinical value of OCT as an alternative or complementary imaging method to conventional histopathology. If OCT proves effective for detecting muscle inflammation, it could become a valuable tool for ultra-rapid diagnosis.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Day
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Healthy patients | – | –Muscle biopsies collected during orthopedic surgery (performed as part of care) |
| Myositis patients | – | –Muscle biopsies collected as part of care to establish a diagnosis |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Myositis or healthy major patients
Key inclusion criteria (2 listed)
- Patient > 18 years old ans has given his oral consent
- Patient who biospies are performed as part of care
Key exclusion criteria (1 listed)
- Patient < 18 years old
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Evaluation of the spatial resolution of the two methods
Time frame: 2 years
Image acquisitions will be performed on the same samples (fresh tissue for OCT and frozen tissue for histology) with an identical section thickness. To obtain structural tissue data, OCT acquisitions will be performed in full field mode (FF-OCT), and Hematoxylin-Eosin, Gomori's trichrome and NADH staining will be carried out on histological sections. For each method, the criteria evaluated will be the ability to detect fiber structure, the presence of fibrosis and blood vessels. Image comparison will be performed by specialized pathologists and then by an autoML type artificial intelligence, with assessment of accuracy and recall.
Evaluation of inflammation detection of the two methods
Time frame: 2 years
Image acquisition will be performed on the same samples (fresh tissue for OCT and frozen tissue for histology) with an identical section thickness. OCT acquisitions will be carried out in dynamic colorimetric mode (DCI) to observe the intensity and variability of metabolic activity across the entire fresh tissue sample using a color panel ranging from blue to red. Inflammation detection on histological sections will be observed using the markers HLA1, HLA-DR, C5B9, P62, CD31, CD56. The potential correlation between metabolic activity and inflammation will be visually assessed by specialized pathologists and by an autoML type artificial intelligence with assessment of accuracy and recall.
1 secondary outcome
Establish the advantages and limitations of the two methods
Time frame: 2 years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Apr 2026.
- Individual participant dataSharing planned: No
Related trials for Myositis
RecruitingPhase 2
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
Dermatomyositis (DM), Juvenile Dermatomyositis (JDM)
RecruitingPhase 1/2
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Systemic Sclerosis, Idiopathic Inflammatory Myopathies
Not yet recruitingPhase 3
A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies
Idiopathic Inflammatory Myopathies
RecruitingObservational study
Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
IBM, Inclusion Body Myositis
RecruitingPhase 2
Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
Dermatomyositis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Myositis and Health Adult Subjects, run by Centre Hospitalier de Mâcon at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 27 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Thibault Maillet, Doctor (+333 85 27 73 43, thmaillet@ch-macon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluation of the spatial resolution of the two methods (time frame: 2 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2026.